Patent · US Active

Antibodies to quetiapine and use thereof

US9410972B2 · kind B2 · utility

17Cited by

16References

20Claims

0Family size

Assignees

Janssen Pharmaceuticals, Inc. · BE
ORTHO-CLINICAL DIAGNOSTICS, INC. · US

Inventors

Eric Hryhorenko · Hilton, US
Banumathi Sankaran · Lexington, US
Thomas R. DeCory · Pittsford, US
Theresa Tubbs · Rochester, US
Linda Colt · Rochester, US
Bart M. Remmerie · Evergem, BE
Rhys Salter · Doylestown, US
Matthew G. Donahue · Hattiesburg, US
Yong Gong · Warrington, US

Key dates

Filing date	Aug 20, 2013
Grant date	Aug 9, 2016
Priority date	—
Expiry date	Apr 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.